Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes

dc.contributor.authorSoupir, Alex
dc.contributor.authorOspina, Oscar E.
dc.contributor.authorHampton, Oliver
dc.contributor.authorChurchman, Michelle
dc.contributor.authorRadmacher, Michael
dc.contributor.authorHedges, Dale
dc.contributor.authorMcKean, David
dc.contributor.authorAgius, Phaedra
dc.contributor.authorZeeshan, Saman
dc.contributor.authorSeligson, Nathan D.
dc.contributor.authorPollock, Raphael
dc.contributor.authorLiebner, David
dc.contributor.authorChen, James L.
dc.contributor.authorTinoco, Gabriel
dc.contributor.authorSalhia, Bodour
dc.contributor.authorMcCarter, Martin
dc.contributor.authorWilky, Breelyn A.
dc.contributor.authorMiller, Benjamin J.
dc.contributor.authorCavnar, Michael J.
dc.contributor.authorGroundland, John S.
dc.contributor.authorSchneider, Bryan P.
dc.contributor.authorRiedlinger, Gregory
dc.contributor.authorEdge, Stephen B.
dc.contributor.authorMoskaluk, Christopher A.
dc.contributor.authorCardona, Kenneth
dc.contributor.authorNaqash, Abdul Rafeh
dc.contributor.authorGonzalez, Ricardo J.
dc.contributor.authorMullinax, John E.
dc.contributor.authorJoyce, David M.
dc.contributor.authorBinitie, Odion
dc.contributor.authorLetson, G. Douglas
dc.contributor.authorNaghavi, Arash O.
dc.contributor.authorDruta, Mihaela
dc.contributor.authorReed, Damon R.
dc.contributor.authorSiegel, Erin M.
dc.contributor.authorTeer, Jamie K.
dc.contributor.authorFridley, Brooke L.
dc.contributor.authorBrohl, Andrew S.
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2025-06-17T07:18:18Z
dc.date.available2025-06-17T07:18:18Z
dc.date.issued2025-05-06
dc.description.abstractGiven their rarity and diversity, a fundamental understanding of the genomic underpinnings for many sarcoma subtypes is still lacking. To better define the molecular landscape of this group of diseases, we perform matched whole exome sequencing and RNA sequencing on a cohort of 1340 sarcoma tumor specimens. We identify recurrent somatic mutations and observe an increased mutational burden in metastatic vs. primary samples (p < 0.001). We observe frequent copy number alterations including whole genome doubling, with this feature being more common in metastatic tumors (p = 0.026). Estimation of immune cell abundances followed by hierarchical clustering identifies five immune subtypes ranging from low to high and we observe inferior overall survival in immune deplete clusters compared to immune enriched (p < 0.01). Interestingly, GIST predominantly form a distinct "immune intermediate" cluster that is marked by a specific enrichment for NK cells (FDR < 0.01).
dc.eprint.versionFinal published version
dc.identifier.citationSoupir A, Ospina OE, Hampton O, et al. Genomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes. Nat Commun. 2025;16(1):4206. Published 2025 May 6. doi:10.1038/s41467-025-58678-6
dc.identifier.urihttps://hdl.handle.net/1805/48770
dc.language.isoen_US
dc.publisherSpringer Nature
dc.relation.isversionof10.1038/s41467-025-58678-6
dc.relation.journalNature Communications
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourcePMC
dc.subjectSarcoma
dc.subjectCancer genomics
dc.subjectGene expression profiling
dc.subjectTranscriptome
dc.titleGenomic, transcriptomic, and immunogenomic landscape of over 1300 sarcomas of diverse histology subtypes
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Soupir2025Genomic-CCBYNCND.pdf
Size:
4.54 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description: